Medical Costs Associated with Use of Systemic Therapy in Adults with Colorectal Cancer

BACKGROUND: New cytotoxic agents and regimens, as well as immunotherapeutics, have recently been introduced for treatment of colorectal cancer (CRC). OBJECTIVES: To identify the patient-related and clinical and treatment-
related factors associated with higher total health care expenditures in newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Seal, Brian S., Sullivan, Sean D., Ramsey, Scott, Shermock, Kenneth M., Ren, Jinma, Kreilick, Charlie, Foltz, Susan H., Valluri, Satish, Sarma, Syam, Asche, Carl V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437395/
https://www.ncbi.nlm.nih.gov/pubmed/23806060
http://dx.doi.org/10.18553/jmcp.2013.19.6.461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437395/
https://www.ncbi.nlm.nih.gov/pubmed/23806060
http://dx.doi.org/10.18553/jmcp.2013.19.6.461

Ejemplares similares